logo
Expecting parents are expecting the worst with UAB and UnitedHealthcare negotiations

Expecting parents are expecting the worst with UAB and UnitedHealthcare negotiations

Yahoo13-06-2025

BIRMINGHAM, Ala (WIAT) – UAB facilities across Alabama could become out-of-network for the thousands of Alabamians insured by UnitedHealthcare.
'Obviously, the hope is they find an agreement and I don't have to swap providers,' Christian Holly said.
Holly and his wife are getting ready to welcome their first child into the world. Their due date is in October and their doctors are at UAB.
'My wife was big on using UAB,' Holly said. 'They've got the best trauma center, the best neo-natal care, all of those sorts of things.'
UAB and UnitedHealthCare (UHC) have until July 31 to finalize an agreement. Each party sent out statements that read in part:
'We are deeply disappointed that UnitedHealthcare has created this uncertainty for our patients…UAB Hospital alone provides more than $100 million a year in care for which it is not paid; and United reimburses care providers less than other insurers.' – UAB Statement.
'UAB continues to drive up health care costs for people and businesses throughout Alabama through its acquisitions…Our goal is to reach an agreement that is affordable for consumers and employers while providing continued, uninterrupted network access to UAB.' – UHC Statement.
The two parties have seven weeks to make that happen.
'If this doesn't get squared away in the next month, we'll have to swap providers,' Holly said.
If UAB becomes out-network for the Holly's, they have two options: pay out of pocket or find a new doctor to deliver their first born. But it's possible both could happen. In the chance his wife needs emergency medical attention during delivery, or their child needs emergency medical care – they'll have to go to UAB and pay out of pocket.
'If she does have an issue, they'll have to swap her to UAB so it just adds a lot of worry to everything,' Holly said.
CBS 42 News requested the total number of Alabamians who are insured through UHC. As of Thursday, we were still waiting for that number. However, thousands of retired public school teachers and their dependents are insured through UHC.
'We have about 80,000 lives that are covered currently through PHIP United Plan,' The Government Media Relations Manger for the Alabama Education Association, Allison King said.
Anyone who worked for the Alabama Public School system for at least 25 years qualifies for Public Education Employees' Health Insurance Plan King said. That plan provides those state retirees with UHC.
'We'll certainly be working to advocate on the behalf of our retirees and make sure they have quality programs both in service providers and health care options,' King said.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

5 Revealing Analyst Questions From Myriad Genetics's Q1 Earnings Call
5 Revealing Analyst Questions From Myriad Genetics's Q1 Earnings Call

Yahoo

time21 hours ago

  • Yahoo

5 Revealing Analyst Questions From Myriad Genetics's Q1 Earnings Call

Myriad Genetics' first quarter results were met with a significant negative market reaction, reflecting investor concerns over a combination of volume softness in key product lines and a reset in full-year expectations. Management attributed the revenue decline primarily to underperformance in its GeneSight pharmacogenomic test, which was affected by UnitedHealthcare's policy change, as well as slower-than-anticipated growth in hereditary cancer screening among unaffected individuals. CEO Sam Raha described the quarter as 'challenging,' highlighting both external payer headwinds and internal operational hurdles, such as workflow disruptions related to electronic medical record (EMR) integrations. The company's leadership openly acknowledged the complexity and execution challenges facing the business. Is now the time to buy MYGN? Find out in our full research report (it's free). Revenue: $195.9 million vs analyst estimates of $200.4 million (3.1% year-on-year decline, 2.3% miss) Adjusted EPS: -$0.03 vs analyst estimates of -$0.05 ($0.02 beat) Adjusted EBITDA: -$100,000 vs analyst estimates of -$1.92 million (-0.1% margin, 94.8% beat) The company dropped its revenue guidance for the full year to $815 million at the midpoint from $850 million, a 4.1% decrease Adjusted EPS guidance for Q2 CY2025 is $0 at the midpoint, below analyst estimates of $0.02 EBITDA guidance for the full year is $23 million at the midpoint, below analyst estimates of $29.85 million Operating Margin: -14.8%, down from -13.8% in the same quarter last year Market Capitalization: $491.3 million While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Doug Schenkel (Wolfe Research) pressed CEO Sam Raha on how long it would take to simplify Myriad's business and clarify key performance metrics. Raha estimated several months for a thorough strategic review and emphasized oncology as the cornerstone of future growth. Puneet Souda (Leerink Partners) questioned whether other payers might follow UnitedHealthcare in dropping coverage for GeneSight. CFO Scott Leffler responded that no similar moves have occurred among other payers and that some incremental coverage wins were achieved. David Westenberg (Piper Sandler) asked for more detail on why EMR integration issues are taking multiple quarters to resolve in hereditary cancer screening. COO Mark Verratti explained that workflow disruptions, account-by-account customization, and patient education requirements are slowing adoption, but efforts are underway to resolve these bottlenecks. Tejas Sawant (Morgan Stanley) sought clarity on the sensitivity requirements for the MRD (minimal residual disease) assay and the broader impact of new oncology product launches. CEO Raha described ongoing clinical studies targeting low-shedding cancers and reaffirmed timelines for product rollouts and evidence generation. Tycho Peterson (Jefferies) inquired about Myriad's liquidity position and the underlying assumptions in the updated guidance. Leffler confirmed that available cash and credit lines are sufficient for 2025, with no material deterioration in reimbursement rates expected. In upcoming quarters, the StockStory team will be watching (1) the pace at which EMR workflow solutions drive volume recovery in hereditary cancer testing, (2) the commercial rollout and adoption of new pipeline products, such as the combined carrier screening and AI-enabled oncology assays, and (3) the effectiveness of cost-control initiatives in supporting margin improvement and liquidity. Progress on payer coverage and revenue cycle management will also be important for tracking Myriad's return to sustainable growth. Myriad Genetics currently trades at $5.09, down from $7.25 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it's free). Market indices reached historic highs following Donald Trump's presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth. While this has caused many investors to adopt a "fearful" wait-and-see approach, we're leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 6 Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Multi-millionaire Trump official Dr. Oz appears not to know how credit cards work
Multi-millionaire Trump official Dr. Oz appears not to know how credit cards work

Yahoo

time2 days ago

  • Yahoo

Multi-millionaire Trump official Dr. Oz appears not to know how credit cards work

Centers for Medicare and Medicaid Administrator Dr. Mehmet Oz appeared to let slip that he doesn't quite grasp how credit cards work. The former revered heart surgeon-turned-television host appeared on Fox News' Ingraham Angle to discuss America's largest health insurance companies pledging to streamline prior authorization. After giving a confusing analogy that compared approving procedures to credit card transactions, Oz made an unintentional admission: he doesn't know how one works. 'We've insisted on a dashboard. They have to be public about what they're doing,' he told Laura Ingraham on Wednesday. 'We want to know, for example, by the end of this year, can you do these examinations instantaneously?' 'Like a credit card,' Oz, who boasts an estimated $200 million net worth, continued. 'When you put it into the machine to buy something, they don't prior authorize you. You either have money in the bank or you don't.' Credit card companies do prior authorization on every transaction to determine whether money can be spent, which includes checking if the card is valid, that there's enough credit available, and if there are any signs of fraud. Individuals also borrow and spend money on their payment cards that they do not physically have in the bank. Oz was seemingly trying to illustrate that medical approvals should be quick and automated, like credit card checks. UnitedHealthcare, Aetna, Cigna, and Humana were among dozens of medical insurance companies that agreed to several measures on Monday, including making fewer medical procedures subject to prior authorization. If the companies follow through, patients would have to jump through fewer bureaucratic hoops, receive faster treatment approvals, and have enhanced continuity of care. Speaking to reporters Monday, Oz said that the pledge is 'not a mandate,' adding: 'This is an opportunity for the industry to show itself.' The CMS head also said he wants insurers to eliminate preapprovals for knee arthroscopy, a common, uncomplicated procedure to diagnose and treat knee issues. On Wednesday, Oz explained that he and Health and Human Services Secretary Robert F. Kennedy Jr. went to the insurance industry directly to tell them their old model was 'inefficient.' ''Secretary Kennedy feels this is wrong, the president feels this is wrong, we have to make a deal,'' he told Ingraham of his apparent dressing down of executives. ''So either you do it or we're gonna do it for you, and it's a lot less painful if you guys get together and figure this out and actually make a pledge.''

Northwestern University performing cost-cutting measures taking effect next year
Northwestern University performing cost-cutting measures taking effect next year

CBS News

time2 days ago

  • CBS News

Northwestern University performing cost-cutting measures taking effect next year

Northwestern University is changing its tuition benefits program and health insurance for its staff and faculty beginning next year. According to the university, the changes are due to rising costs and other factors straining the school's finances. In an email earlier this month, the university informed staff and faculty that on Jan. 1, 2026, it will change from Blue Cross Blue Shield to UnitedHealthcare and new dental and prescription insurance providers. The move is forcing staff to petition the board of trustees to allow them to keep the Blue Cross. The university said that without the changes, employees would pay more, and the school would be forced to make additional cuts in other areas beyond what they've already announced. Changes to the tuition benefits program, which allows staff to take courses at a discount, will also be made for new and returning hires. Current faculty and staff will not be affected by the changes. Now, the school will cap the program at $12,000 per year.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store